Every Cure: Unlocking Drug Potential With Artificial Intelligence With Waqas Haque and Tracey Sikora

In this installment of Oncology Data Advisor's Exploring Artificial Intelligence in Oncology series, Dr. Waqas Haque, Fellows Forum member and incoming Hematology/Oncology Fellow at the University of Chicago, speaks with Tracey Sikora, Co-Founder of Every Cure, a nonprofit organization whose mission is to repurpose existing FDA-approved drugs for other indications, especially in rare diseases. Check out the discussion to learn more about: • Challenges in finding treatments for rare diseases, including sparse data, low patient numbers, and lack of financial incentive for pharmaceutical companies • Every Cure’s mission to unlock the potential of drugs that are already on the market • Harnessing the latest AI and machine learning technology to structure data in a biomedical knowledge graph, looking at drugs, diseases, pathways, and targets • Barriers in drug repurposing, including clinical validation and eventual approval • The Advanced Research Projects Agency for Health (ARPA-H) grant and the importance of federal funding for rare disease research • How to develop efficient clinical trials without a large sample size • The future of AI-enabled drug discovery in oncology • And more!